Beurs.nl monitor iconMarkt Monitor
  • AEX -7,22 907,46 -0,79%
  • DE40 0,00 22.678,74 0,00%
  • US500^ -136,63 5.556,95 -2,40%
  • US30^ -884,70 41.429,80 -2,09%
  • EUR/USD +0,00 1,0831 +0,32%
  • WTI -0,96 68,98 -1,37%
  • Gold spot +30,30 3.085,30 +0,99%

Pharming april 2018

7.620 Posts
Pagina: «« 1 ... 68 69 70 71 72 ... 381 »» | Laatste | Omlaag ↓
  1. [verwijderd] 5 april 2018 14:58
    quote:

    TommyTP schreef op 5 april 2018 14:36:

    [...]

    EEN GROOT RISICO voor Pharming. IEDEREEN kan konijnen genetisch manipuleren en heel simpel een vergunningen krijgen voor een bioreactor fabriek... Los van de overal verkrijgbare techniek om konijnen te melken...


    Deze ouwe koek is nog lekker voor jou.

    www.pharming.com/fda-grants-ruconest-...
    The determination of exclusivity ensures that FDA will not approve before July 16, 2026 any applications for biosimilars of RUCONEST

    Transgenic Production Technology Platform (TPTP)

    After the discovery of DNA and recombinant DNA techniques in the past decades it became possible to transfer genes between different organisms, such as plants and bacteria. Scientists discovered how to transfer mammalian genes into the genetic material of other animals, and breed transgenic animals with specific (mixed) characteristics. This new scientific approach of recombining genetic material from different biological sources became known as recombinant DNA technology and the animals generated with such technology as transgenic animals.
    Therapeutic proteins from milk

    Pharming’s predecessor company GenPharm was founded to commercialize this innovative technology. The Pharming scientists were able to breed animals that could produce human-like proteins in their milk. The company further improved this technology and made it fully compliant with regulatory guidelines that apply in the United States and Europe.
    Large-scale manufacturing

    For commercial purposes, Pharming also developed large scale purification methods for separating the human proteins from the other natural components in milk. The purification process for our lead product Ruconest was successfully up-scaled and transferred to the current manufacturing partner Sanofi Chimie. All production facilities and processes comply with regulatory GMP-guidelines and are suitable for large-scale production of the highest quality pharmaceutical products.
    High quality in sufficient quantity

    Pharming can produce complex therapeutic proteins in the mammary glands of rabbits or cattle and purify the protein from milk for its therapeutic application. This production method has the advantage of delivering high quality human proteins in sufficient quantities and consistently high quality. Pharming is the first company in the world to obtain regulatory approval for a recombinant protein pharmaceutical produced in milk of transgenic rabbits. The technology platform has been developed such that consistency of the product attributes is easily maintained through scaling up of the production process. Furthermore the transgenic rabbit platform has been optimized by Pharming to produce large quantities of recombinant proteins in a controlled, easily transferrable and scalable fashion.
    High potential

    There is a need in the industry for new means to produce over 900 protein therapeutics that are currently in development. Pharming believes that its production technology offers significant competitive advantages and will enable the development of better, safer and more cost-effective therapeutic products.

    As of July 2013, Pharming has partnered the technology platform with The Shanghai Institute of Pharmaceutical Industry (SIPI); a Sinopharm Company.
    This strategic collaboration for the development, manufacture and commercialization of new products based on Pharming’s technology platform, allows SIPI access to Pharming’s technology and know-how such that a joint global development of new products can benefit both parties.
    Intellectual Property (IP)

    The company owns and has in-licensed a significant number of patents and patent applications worldwide, broadly covering the technology for the production of recombinant proteins in the milk of transgenic animals, as well as the specific products under development. Protection for recombinant proteins currently produced in milk as well as methods of generating transgenic animals will last beyond 2020.

    Typically, various aspects of manufacturing and use of Pharming’s products are covered by separate patents, trade secrets and know- how, thus creating several independent layers of protection around each product. For instance, Pharming’s IP position in the production and use of Ruconest not only covers the therapeutic compound itself, but also methods of production and purification, improved versions of Ruconest, and therapeutic use in a large number of medical indications, including (but not limited to) HAE and other diseases linked to C1 inhibitor deficiency.

    In the field of transgenic technology, Pharming’s portfolio includes the following IP:

    Generation and use of transgenic cattle
    Milk specific expression in transgenic animals
    Animals carrying large transgenes (> 50kb)
    Purification of biopharmaceuticals from milk
    Structure and design of transgenes for high level production
    Fusion proteins for high level expression
    Generation of animals using nuclear transfer technology
    Oocyte activation for nuclear transfer
    Transgenic antibody production
    Sperm mediated gene transfer

    For applications outside of Pharming’s core activities, this IP is available for licensing.

  2. forum rang 5 antop 5 april 2018 14:58
    Antop is al op 1,75 draadje...KarenT en Patrick22 eruit en LT Up naar de 1,30 en hoger...Let maar UP!
    Nog geen 13 milj verhandeld dat gaat leuk worden komende tijd...0,20 en hoger LT! 100 milj verhandeld!PB de Vries met Update..;-)Fijne dag
  3. [verwijderd] 5 april 2018 15:00
    quote:

    Muppet_Waldorf schreef op 5 april 2018 14:57:

    [...]

    Logisch, die WETEN dat het volgende week weer lager staat.

    Ik ZOU natuurlijk kunnen overwegen om alvast 30 % eruit te doen .... dat doen er wel meer hier.

    Doe maar, en dan ksssst wegwezen verder...
  4. DagoHar 5 april 2018 15:04
    je zal ze gister maar tegen 1,15 hebben weggedaan..., zonder nieuws knalt het gelukkig weer eens omhoog..., kan morgen zomaar weer 1,35 staan...
  5. [verwijderd] 5 april 2018 15:06
    quote:

    DagoHar schreef op 5 april 2018 15:04:

    je zal ze gister maar tegen 1,15 hebben weggedaan..., zonder nieuws knalt het gelukkig weer eens omhoog..., kan morgen zomaar weer 1,35 staan...
    Zou lekker zijn..

    Hebben de zittenblijvers LT of KT wel verdiend denk ik.
    Zou lekker zijn als we geen rood meer zien voor het weekend!
  6. [verwijderd] 5 april 2018 15:12
    quote:

    alles-niks schreef op 5 april 2018 15:09:

    Waar is de tandsteen gebleven?
    Naar de tandarts onder zware behandeling?
    Is onbehandelbaar...... zit nu in een gesloten inrichting :--))
  7. jaapaap 5 april 2018 15:13
    morgen licht de hele club van de pharmers in de compagnie bar aan de haven, dronken achter de bar!
  8. [verwijderd] 5 april 2018 15:16
    quote:

    lucas D schreef op 5 april 2018 13:45:

    [...]

    Kruisjes, het zijn geen speldjes maar kruisjes. Wanneer je de tocht 5x rijd, dan krijg je een zilveren kruisje.
    En je hoeft niet eens mee te rijden om er toch van te genieten, toeschouwers zijn er nooit genoeg.

    Klopt, maar zijn dat dezelfde die ik bedoel, van heel lang geleden ook nog en ik sta er ook van te genieten, woon je in Friesland?
  9. [verwijderd] 5 april 2018 15:16
    quote:

    Misschien schreef op 5 april 2018 15:12:

    Blokkies van een half miljoen durven ze er niet meer in te gooien!
    Ze worden opgevreten.....

    Lekker Jager, dat geeft de burger weer moed!

    Tini
    Geeft een heel goed gevoel.
7.620 Posts
Pagina: «« 1 ... 68 69 70 71 72 ... 381 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beurs.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.119
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.173
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.857
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.839
Aedifica 3 926
Aegon 3.258 323.075
AFC Ajax 538 7.089
Affimed NV 2 6.305
ageas 5.844 109.905
Agfa-Gevaert 14 2.063
Ahold 3.538 74.353
Air France - KLM 1.025 35.290
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.276
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 420
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.905
AMG 971 134.353
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.056
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.806
Arcelor Mittal 2.034 320.985
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.352
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.614
ASML 1.766 110.161
ASR Nederland 21 4.512
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.937
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449